Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03746301

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation — XARENAL  

Non-valvular Atrial Fibrillation (NVAF) Clinical Trial

Official title:
Xarelto® on Prevention of Stroke and Non-Central Nervous Systemic (CNS) Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation (NVAF)

Clinical Trial Summary

The purpose of the study is to evaluate the safety and effectiveness of Xarelto in renally impaired patients with NVAF under routine practice conditions. The information collected in the XARENAL study will help to understand how renally impared patients with NVAF are treated in the real-world setting and what the outcome for the patients is under those conditions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03746301
Study type Observational
Source Bayer
Contact
Status Completed
Phase
Start date December 3, 2018
Completion date December 15, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT05022758 - A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin
Active, not recruiting NCT03887780 - A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)
Completed NCT02954237 - AMPLATZER™ Cardiac Plug Observational Post-Approval Study
Completed NCT01598051 - Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
Completed NCT04356989 - Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function
Recruiting NCT05232643 - A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
Recruiting NCT03234114 - Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Phase 4
Completed NCT02663076 - Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Withdrawn NCT02153424 - Early Post-marketing Study of Eliquis (Apixaban) N/A
Completed NCT05027061 - A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan